ArticleAnnals of nuclear medicine2024

Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy.

Hsi-Huei Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.